Neil R. Anderson
Purdue University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Neil R. Anderson.
Drug Development and Industrial Pharmacy | 1984
John J. Motzi; Neil R. Anderson
AbstractThe processing variables associated with the comminution of pharmaceutical granulations were investigated. The three variables chosen were mill speed, output screen size and impeller shape. Experiments were performed on an aspirin granulation using proper techniques of experimental design. Analysis showed that the three mill variables cannot be considered independently but rather at the level of combinations. A complete characterization of the mill output according to particle size distribution is then possible based upon these combinations of mill variables.
Drug Development and Industrial Pharmacy | 1984
John J. Motzi; Neil R. Anderson
AbstractRegression analysis was performed using comminution data from the previously presented Comil®G/aspirin granulation characterization study. Polynomial models were constructed using mill speed, output screen size and impeller shape as independent variables. The models were used to predict the mean particle size (µd) and geometric standard deviation (σd) of particle size distributions resulting from the comminution of aspirin using the Comil®G. The predictions were found to compare well with observed values.
Drug Development and Industrial Pharmacy | 1981
Neil R. Anderson; V. L. Anderson; Garnet E. Peck
AbstractBy Incorporating restriction errors into experimental design models, the developmental scientist is forced to consider what restrictions on randomization have been placed on his experiment whether they are inadvertent or planned. With the experimental design in mind along with the restriction errors the scientist should be able to eventually establish a very reasonable design model and analysis for that experiment.One of the more fundamental tools of pharmaceutical research and development, particularly in the design of dosage forms, is that of the accelerated stability test (1). In general, accelerated testing done early in the development scheme is designed to screen the formulation for the effects caused by changing variables. Variables are anything associated with the formula or the manufacturing of the formula. Many developmental scientists would change only one variable at a time. While this may be sound advice occasionally, it is time consuming and could actually miss the most important eff...
Drug Development and Industrial Pharmacy | 1984
John J. Motzi; Neil R. Anderson
AbstractA method is presented which may be used to mathematically express particle size distributions of pharmaceutical granulations.The method utilizes expresses of particle size and probability evaluated using a weighted linear regression technique. This method is suggested whenever particle size determinations are used in conjunction with statistical analysis, optimization techniques or any time a purely quantitative approach is needed.
Journal of parenteral science and technology : a publication of the Parenteral Drug Association | 1985
Ronald E. Peeples; Neil R. Anderson
Journal of Pharmaceutical Sciences | 1982
Neil R. Anderson; Gilbert S. Banker; Garnet E. Peck
Journal of Pharmaceutical Sciences | 1982
Neil R. Anderson; Gilbert S. Banker; Garnet E. Peck
Journal of parenteral science and technology : a publication of the Parenteral Drug Association | 1985
Ronald E. Peeples; Neil R. Anderson
Journal of parenteral science and technology : a publication of the Parenteral Drug Association | 1985
Wendy A. Preston; Neil R. Anderson
Archive | 1984
John J. Motzi; Neil R. Anderson